Please select the option that best describes you:

Do you hold nivolumab and ipilimumab when giving palliative radiation to abdominal targets?  

Answer from: Radiation Oncologist at Academic Institution
Radiation Oncologist at Brigham and Women's Hospital
I agree with continuing the checkpoint inhibition ...
Sign in or Register to read more